Corp. SVP BioPharma Network

Corporate Vice President

Mars, Hill’s, Zoetis Join HABRI to Chart Path Toward Sustainable Future for Veterinary Medicine

Idiopathic Pulmonary Fibrosis Diagnostic and Treatment Market Forecasts Report 2025-2030 | Boehringer Ingelheim and FibroGen Lead by Driving Innovations in Pharmacological and Diagnostic Advancements

FDA grants Hernexeos ‘Breakthrough’ status in NSCLC

Urea Cycle Disorder Treatment Market Outlook 2035: Rising to US$ 771 Mn at 3.5% CAGR | Transparency Market Research

Executive Director, ExpMED Oncology Targeted Therapy

Boehringer Ingelheim is a global leader in healthcare, dedicated to improving lives through innovation. The Executive Director, ExpMED Oncology Targeted Therapy will provide medical strategic leadership in Experimental Medicine Oncology, overseeing clinical development and ensuring alignment across scientific platforms and communication strategies.

Vice President, Human Pharma Business Law

Vice President, Cancer Immunology & Immune Modulation

Executive Director, US Regulatory Affairs Lead, Oncology

Senior Vice President, Global Head Cancer Immunology & Immune Modulation

Senior Associate Director, Medical Strategy Team

Sign up with Google

Sign in with Google